0001213900-24-047639.txt : 20240529 0001213900-24-047639.hdr.sgml : 20240529 20240529212508 ACCESSION NUMBER: 0001213900-24-047639 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240524 FILED AS OF DATE: 20240529 DATE AS OF CHANGE: 20240529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TRAVERSA SERGIO CENTRAL INDEX KEY: 0001565832 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39082 FILM NUMBER: 241000532 MAIL ADDRESS: STREET 1: 138 CANTERBURY LN CITY: BLUE BELL STATE: PA ZIP: 19422 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001553643 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 455401931 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: 646 876 3459 MAIL ADDRESS: STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CAMP NINE, INC. DATE OF NAME CHANGE: 20120706 4 1 ownership.xml X0508 4 2024-05-24 0 0001553643 RELMADA THERAPEUTICS, INC. RLMD 0001565832 TRAVERSA SERGIO C/O RELMADA THERAPEUTICS, INC. 2222 PONCE DE LEON BLVD, 3RD FLOOR CORAL GABLES FL 33134 1 1 0 0 Chief Executive Officer 0 Stock Option (right to buy) 2.48 2024-05-24 4 A 0 122358 0 A 2024-03-15 2033-12-15 Common Stock 122358 306239 D Stock Option (right to buy) 2.48 2024-05-24 4 J 0 122358 0 D 2024-03-15 2033-12-15 Common Stock 122358 183881 D On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 122,358 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer. /s/ Sergio Traversa 2024-05-29